10th International Diabetes Summit 2026

The 10 International Diabetes Summit -2026 (IDS) was organized by Chellaram Diabetes th th Institute from 13 – 15 March 2026 at Hotel J W Marriott, Pune.

The summit was a grand success, attracting over 3,000 registrations and achieving an impressive attendance of 2,800 delegates. More than 70 speakers from across India, along with 10 distinguished international faculty members from the US and Europe, and 130 chairpersons, contributed significantly to the success of the event. The Run for Diabetes Awareness also witnessed an overwhelming response, with 600 registrations and participation from more than 550 attendees.

The three days of the summit saw wide-ranging scientific discussions and knowledge sharing deliberations on practical strategies to address the rising burden of diabetes and its complications in India and the world over.

The International Diabetes Summit was inaugurated by: Dr. Vinky Rughwani (Administrator of the Maharashtra Medical Council, Mumbai, Member of the National Sickle Cell Elimination Mission under the Ministry of Health and Family Welfare, Government of India, and President of the Thalassemia and Sickle Cell Society of India). Dr. Vinky Rughwani emphasized the need for a strong system that promotes extensive discussion, research, and innovation to address this issue, Mr. Prakash Bhoopatkar (Vice Chairman, Chellaram Foundation), Dr. A.G. Unnikrishnan (CEO of Chellaram Diabetes Institute) and Wing Commander (Dr.) Harshal More (Retd.) (CMD of Chellaram Hospital) graced the ceremony with their presence.

During the event, Dr. Carani B. Sanjeevi (Professor at the Karolinska Institutet, Sweden, and head of the Diabetes Immunology research group at the Center for Molecular Medicine at Karolinska University Hospital in Stockholm) was felicitated with the Lifetime Achievement Award in recognition of his outstanding contribution in the field of diabetes research.The scientific sessions focused on key issues namely managing diabetes complications, costeffective diabetes care, emerging advances in treatment, and the increasing role of technology in diabetes management.

Several eminent international speakers from leading institutions like the Mayo Clinic in the United States; King’s College London, Imperial College London, University of Suffolk, University of Leicester, and University of Edinburgh in the United Kingdom; the Medical University of Graz in Austria; and the National University of Singapore; participated in the summit along with more than 70 renowned Indian faculty members, making the event a truly global platform for advancing diabetes care.

The summit also featured specialized workshops on Artificial Intelligence in Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Diabetes, as well as a symposium focusing on Endocrinology and Women’s Health, highlighting emerging clinical challenges and research developments in these areas.